Taiwan aligns its drug registration with international standards by adopting guidelines from the International Council for Harmonisation (ICH) and collaborating with regulatory bodies like the US FDA and EMA. The TFDA ensures compliance with Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP), facilitating the acceptance of foreign clinical data through harmonized processes.
